Edwards Lifesciences Revenue

Edwards Lifesciences Corporation -- USA Stock  

USD 118.18  0.15  0.13%

The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners to view more equity screening tools
Symbol
Refresh

Revenue Analysis

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.
Edwards Lifesciences 
Revenue 
 = 
Money Received 
Discounts and Returns 
 = 
3.31 B

Distress Driver Correlations

 Edwards Lifesciences Revenues 
      Timeline 

About Revenue

Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare to competition

Edwards Lifesciences Revenue Assessment

Revenue

Edwards Lifesciences Revenue Change Over Time

Cost of Revenue

Based on latest financial disclosure Edwards Lifesciences Corporation reported 3.31 B of revenue. This is 49.08% lower than that of the Healthcare sector, and significantly higher than that of Healthcare Products industry, The Revenue for all stocks is 66.38% higher than the company.

Peer Comparison

Edwards Lifesciences Revenue Comparison
  Revenue 
      Edwards Lifesciences Comparables 
Edwards Lifesciences is rated below average in revenue category among related companies.

Did you try this?

Run Portfolio Suggestion Now
   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
Hide  View All  NextLaunch Portfolio Suggestion